Surya Gummadi, the President - Americas of $CTSH, sold 1,728 shares of the company on 02-02-2026 for an estimated $143,523. We received data on the trade from a recent SEC filing. This was a sale of approximately 6.3% of their shares of this class of stock. Following this trade, they now own 25,641 shares of this class of $CTSH stock.
$CTSH Insider Trading Activity
$CTSH insiders have traded $CTSH stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.
Here’s a breakdown of recent trading of $CTSH stock by insiders over the last 6 months:
- MICHAEL PATSALOS-FOX has made 0 purchases and 8 sales selling 31,965 shares for an estimated $2,607,417.
- SURYA GUMMADI (President - Americas) has made 0 purchases and 4 sales selling 22,728 shares for an estimated $1,797,954.
- JOHN SUNSHIN KIM (CLO, CAO & Corporate Secretary) has made 0 purchases and 3 sales selling 10,000 shares for an estimated $806,355.
- RAVI KUMAR SINGISETTI (Chief Executive Officer) has made 0 purchases and 2 sales selling 6,075 shares for an estimated $500,974.
- ALINA KERDMAN (SVP, Controller & CAO) has made 0 purchases and 4 sales selling 881 shares for an estimated $65,005.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CTSH Hedge Fund Activity
We have seen 486 institutional investors add shares of $CTSH stock to their portfolio, and 497 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 3,949,442 shares (+79.4%) to their portfolio in Q3 2025, for an estimated $264,889,074
- WELLINGTON MANAGEMENT GROUP LLP removed 3,278,541 shares (-42.1%) from their portfolio in Q3 2025, for an estimated $219,891,744
- PACER ADVISORS, INC. removed 2,187,045 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $181,524,735
- VOLORIDGE INVESTMENT MANAGEMENT, LLC added 1,870,834 shares (+801.4%) to their portfolio in Q3 2025, for an estimated $125,476,836
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC added 1,554,648 shares (+144.3%) to their portfolio in Q3 2025, for an estimated $104,270,241
- NOMURA HOLDINGS INC removed 1,164,464 shares (-69.4%) from their portfolio in Q3 2025, for an estimated $78,100,600
- GOLDMAN SACHS GROUP INC removed 1,155,874 shares (-16.5%) from their portfolio in Q3 2025, for an estimated $77,524,469
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CTSH Revenue
$CTSH had revenues of $5.3B in Q4 2025. This is an increase of 4.94% from the same period in the prior year.
You can track CTSH financials on Quiver Quantitative's CTSH stock page.
$CTSH Analyst Ratings
Wall Street analysts have issued reports on $CTSH in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 11/21/2025
- Wells Fargo issued a "Overweight" rating on 10/30/2025
- JP Morgan issued a "Overweight" rating on 10/30/2025
- Guggenheim issued a "Buy" rating on 10/21/2025
To track analyst ratings and price targets for $CTSH, check out Quiver Quantitative's $CTSH forecast page.
$CTSH Price Targets
Multiple analysts have issued price targets for $CTSH recently. We have seen 7 analysts offer price targets for $CTSH in the last 6 months, with a median target of $86.0.
Here are some recent targets:
- Jonathan Lee from Guggenheim set a target price of $100.0 on 01/28/2026
- Bryan Keane from Citigroup set a target price of $86.0 on 01/22/2026
- Jason Kupferberg from Wells Fargo set a target price of $98.0 on 01/14/2026
- Bryan Bergin from TD Cowen set a target price of $84.0 on 01/09/2026
- Kevin Mcveigh from UBS set a target price of $82.0 on 12/08/2025
- Daniel R. Perlin from RBC Capital set a target price of $82.0 on 10/30/2025
- Tien-Tsin Huang from JP Morgan set a target price of $92.0 on 10/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.